Inquiry Basket
Loading ......
Filter By Product Search for
CDK5
CDK5 Full Name
cyclin-dependent kinase 5
CDK5 Introduction
CDK5 (cyclin-dependent kinase 5) is a unique member of the cyclin-dependent kinase family that differs from classical cell cycle CDKs because its primary functions are linked to neuronal development, synaptic regulation, and nervous system homeostasis rather than cell cycle progression. Unlike CDK1, CDK2, or CDK4, CDK5 is predominantly activated by the neuron-specific regulatory proteins p35 and p39, allowing it to control essential processes in post-mitotic neurons. Current evidence identifies CDK5 as a master regulator of neuronal migration, axon guidance, dendritic spine formation, synaptic maturation, neurotransmitter release, and learning-associated plasticity. Because neurological disorders often involve disrupted neuronal connectivity and signaling, researchers increasingly view CDK5 as a critical molecular hub that links normal brain development to neurodegenerative and neuropsychiatric disease mechanisms. In healthy tissues, tightly controlled CDK5 activity supports neuronal survival and functional network formation, making it one of the most extensively studied kinases in neuroscience.
A key challenge in neurobiology is understanding how a kinase that is indispensable for neuronal function becomes pathogenic under disease conditions. Studies over the past three decades have demonstrated that CDK5 activity is normally regulated through transient association with p35 or p39. Under cellular stress, oxidative damage, excitotoxicity, or neurotoxic stimulation, the protease calpain can cleave p35 into a more stable fragment known as p25. The resulting CDK5/p25 complex exhibits prolonged and mislocalized kinase activity, leading to abnormal phosphorylation of multiple neuronal substrates, including tau protein and cytoskeletal regulators. This pathological switch has been strongly associated with synaptic dysfunction, impaired neuronal signaling, mitochondrial abnormalities, and progressive neuronal loss. Emerging evidence further suggests that CDK5 influences circadian rhythm regulation, neuroinflammation, immune-cell migration, and intracellular trafficking pathways, highlighting its broad biological significance beyond classical neuronal development. As a result, CDK5 is increasingly recognized not only as a signaling kinase but also as a central coordinator of neuronal adaptation and stress responses.
The disease relevance of CDK5 continues to expand across both neurological and non-neurological fields. Aberrant CDK5 activation has been implicated in major neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and various forms of cognitive decline. In Alzheimer's disease, excessive CDK5/p25 activity contributes to tau hyperphosphorylation, neurofibrillary pathology, and neuronal degeneration. In Parkinson's disease, dysregulated CDK5 signaling participates in dopaminergic neuron loss and neuroinflammatory responses, prompting significant interest in CDK5-targeted therapeutic strategies. Recent studies have also revealed that CDK5 modulates synaptic plasticity in Huntington's disease models, suggesting an important role during early neurodegenerative progression. Beyond the nervous system, growing evidence indicates that cancer-associated signaling pathways can hijack CDK5 activity through sustained p35 expression, promoting tumor cell migration, invasion, angiogenesis, and metastatic potential. This dual role—as an essential regulator of neurodevelopment and a disease-driving kinase when aberrantly activated—has positioned CDK5 as a highly attractive therapeutic target and biomarker candidate for neuroscience, oncology, and translational drug discovery research.
Alternate Names for CDK5
CDK5; cyclin-dependent kinase 5; PSSALRE; cyclin-dependent-like kinase 5; TPKII catalytic subunit; protein kinase CDK5 splicing; cell division protein kinase 5; serine/threonine-protein kinase PSSALRE; tau protein kinase II catalytic subunit;
Loading ......
